Literature DB >> 29976278

A Cohort Study of Incidences and Risk Factors for Thromboembolic Events in Patients with Idiopathic Membranous Nephropathy.

Pei-Mei Zou1, Hang Li1, Jian-Fang Cai1, Zhen-Jie Chen1, Chao Li1, Ping Xu2, Ming-Xi Li1, Li-Meng Chen1, Xue-Mei Li1, Xue-Wang Li1.   

Abstract

Objective The aims of this study were to assess incidences and characteristics of arterial thromboembolic events (ATEs) and venous thromboembolic events (VTEs) in Chinese patients with idiopathic membranous nephropathy (IMN), and to identify the predisposing risk factors of them.Methods A total of 766 consecutive Chinese patients with IMN were enrolled in this retrospective cohort study. The cumulative incidences of newly diagnosed ATEs and VTEs were calculated using Kaplan-Meier methods. Univariable risk prediction model analysis followed by multivariable survival analysis was used to evaluate the potential risk factors of ATE and VTE.Results At 0.5, 1, 2, 3, and 5 years after biopsy diagnosis of IMN, the cumulative incidence of newly diagnosed ATEs were 4.3%, 5.7%, 6.3%, 7.1%, and 8.0%, and of newly diagnosed VTEs were 5.9%, 6.8%, 6.9%, 7.0%, and 7.2%, respectively. In 78 ATEs events (71 patients), cardiovascular diseases, thrombotic ischemic stroke (IS) and peripheral artery disease accounted for 50%, 45% and 5% respectively; in 60 VTEs events(53 patients), the deep vein thrombosis, renal vein thrombosis and pulmonary embolism accounted for 60%, 13% and 27% respectively. At the time of event, 42.1% patients with ATEs and 81.5% patients with VTEs were at nephrotic syndrome(NS) status (χ 2=18.1, P<0.001). Severe proteinuria, aging, smoking, hypertension and prior ATE history were associated with ATEs. Aging was demonstrated as the independent risk factor for ATEs (P=0.001), and hypoalbuminemia was the dominant independent risk factor for VTEs (P=0.03). Conclusions Patients with IMN have increased incidences of ATEs and VTEs, and most of events occurred within the first 6 months of the disease. IS was very common in ATEs in our cohort. Severe proteinuria and classic risk factors for atherosclerosis were associated with onset of ATEs. Hypoalbuminemia independently predicted VTEs. Risks of both ATEs and VTEs were particularly high in the status of NS, particularly VTEs.

Entities:  

Mesh:

Year:  2018        PMID: 29976278     DOI: 10.24920/11809

Source DB:  PubMed          Journal:  Chin Med Sci J        ISSN: 1001-9294


  11 in total

1.  Risk Prediction and Treatment of LE-DVT in Patients with Chronic Radiation Intestinal Injury: A Retrospective Case-Control Study.

Authors:  Xiaoyan Huang; Yingyi Kuang; Qiyuan Qin; Hui Wang; Tenghui Ma; Xinjuan Fan; Miaomiao Zhu; Yanjiong He; Zixu Yuan; Huaiming Wang; Qinghua Zhong; Qi Guan
Journal:  Cancer Manag Res       Date:  2021-08-23       Impact factor: 3.989

Review 2.  Advances in Pathogenesis of Idiopathic Membranous Nephropathy.

Authors:  Zhifeng Xu; Lu Chen; Huiling Xiang; Chun Zhang; Jing Xiong
Journal:  Kidney Dis (Basel)       Date:  2020-06-02

Review 3.  Prevalence of pulmonary thromboembolism in nephrotic syndrome patients: A systematic review and meta-analysis.

Authors:  Abdullah Nasser Leslom; Ziyad Mohammed Saeed Alrawiah; Ahmed Mohammed Ahmed Al-Asmari; Moneer Dhafer Ali Alqashaneen; Abdulaziz Oudah Tami Alahmari; Hamuod Oudah Bin Tami Al-Ahmari
Journal:  J Family Med Prim Care       Date:  2020-02-28

4.  A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome.

Authors:  Raymond Lin; Georgina McDonald; Todd Jolly; Aidan Batten; Bobby Chacko
Journal:  Kidney Int Rep       Date:  2019-12-12

5.  Statins can benefit patients with primary membranous nephropathy on venous thromboembolism.

Authors:  Peimei Zou; Hang Li; Jianfang Cai; Zhenjie Chen; Chao Li; Xuewang Li
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

6.  The Association of Syndecan-1, Hypercoagulable State and Thrombosis and in Patients With Nephrotic Syndrome.

Authors:  Xin Chen; Xuemei Geng; Shi Jin; Jiarui Xu; Man Guo; Daoqi Shen; Xiaoqiang Ding; Hong Liu; Xialian Xu
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

7.  Anti-PLA2R antibody measured by ELISA predicts the risk of vein thrombosis in patients with primary membranous nephropathy.

Authors:  Huizi Zhu; Liang Xu; Xiang Liu; Bing Liu; Chunjuan Zhai; Rong Wang; Xiaowei Yang
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

8.  Management of anticoagulation and antiplatelet therapy in patients with primary membranous nephropathy.

Authors:  Honghong Zou; Yebei Li; Gaosi Xu
Journal:  BMC Nephrol       Date:  2019-12-02       Impact factor: 2.388

9.  Effects of Short-Term Proteinuria on the Incidence of Stroke in Patients With Different Glucose Tolerance Status.

Authors:  Ahlim Alsanani; Joseph I Shapiro
Journal:  J Am Heart Assoc       Date:  2020-06-13       Impact factor: 5.501

10.  Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome-A retrospective observational study.

Authors:  Frida Welander; Henrik Holmberg; Emöke Dimény; Ulf Jansson; Anders Själander
Journal:  PLoS One       Date:  2021-07-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.